247 related articles for article (PubMed ID: 37853331)
1. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D; Lopriore E
BMC Pregnancy Childbirth; 2023 Oct; 23(1):738. PubMed ID: 37853331
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D
BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
[TBL] [Abstract][Full Text] [Related]
5. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
6. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
7. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
Blyth U; Larsson M; Baird A; Waring G; Athiraman N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
[TBL] [Abstract][Full Text] [Related]
8. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
9. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
10. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
11. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
Sahoo D; Anuragaa S; Abhishekh B
Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
[TBL] [Abstract][Full Text] [Related]
14. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion.
Seheult JN; Stram MN; Pearce T; Bub CB; Emery SP; Kutner J; Watanabe-Okochi N; Sperry JL; Takanashi M; Triulzi DJ; Yazer MH
Vox Sang; 2021 Aug; 116(7):831-840. PubMed ID: 33491789
[TBL] [Abstract][Full Text] [Related]
15. The Outcome of Hemolytic Disease of the Fetus and Newborn Caused by Anti-Rh17 Antibody: Analysis of Three Cases and Review of the Literature.
Dajak S; Ipavec N; Cuk M; Golubic Cepulic B; Mratinovic-Mikulandra J; Milardovic J; Stefanovic V
Transfus Med Hemother; 2020 Jun; 47(3):264-271. PubMed ID: 32595431
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic Disease of the Fetus and Newborn: Historical and Current State.
Jackson ME; Baker JM
Clin Lab Med; 2021 Mar; 41(1):133-151. PubMed ID: 33494881
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province].
Liu X; LE F; Wang LH; Shu J; Xu XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):215-220. PubMed ID: 36765502
[TBL] [Abstract][Full Text] [Related]
18. Haemolytic disease of the fetus and newborn.
de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
[TBL] [Abstract][Full Text] [Related]
19. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?
Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E
Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759
[TBL] [Abstract][Full Text] [Related]
20. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]